Healthcare -
Biotechnology - NASDAQ - US
$ 32.775
-6.65 %
$ 200 M
Market Cap
-16.55
P/E
MNPR - OTHER ACCUMULATIVE COMPREHENSIVE INCOME LOSS
Other Accumulative Comprehensive Income Loss MNPR - Monopar Therapeutics Inc.
-14.1 K
LAST VALUE
-111.47%
2 YEAR CAGR
-42.61%
5 YEAR CAGR
0.00%
10 YEAR CAGR